Ischemic%20stroke Signs and Symptoms

Signs and Symptoms

Introduction

Stroke or cerebrovascular disease is defined as a sudden onset of focal neurological deficit or any alteration in level of consciousness due to an underlying vascular pathology
- Brain involvement is evident clinically or as documented in imaging studies based on the onset of symptoms
Ischemic stroke is a type of stroke characterized by the sudden absence of blood supply to an area of the brain, spinal cord or retina secondary to a thrombus, emboli, or intracranial small vessel disease
Most common risk factors include hypertension and diabetes mellitus
Rapid evaluation is essential for use of time-sensitive treatments and to prevent further brain damage

Signs and Symptoms

Common Presentation of Patients with Acute Ischemic Stroke

Left (dominant) Hemisphere

Left gaze preference
Right visual field deficit
Right hemiparesis
Right hemisensory loss
Dysarthria
Aphasia (Broca’s, Wernicke’s, Global)
Apraxia
Visual agnosia

Right (non-dominant) Hemisphere

Right gaze preference
Left visual field deficit
Left hemiparesis
Left hemisensory loss (hemi-inattention)
Neglect of left side
Dysarthria

Brainstem

Nausea/vomiting
Diplopia, dysconjugate gaze, gaze palsy, nystagmus
Dysarthria, dysphagia
Vertigo, syncope
Hemiparesis or quadriplegia
Sensory loss in hemibody or all 4 limbs
Decreased consciousness
Hiccups, abnormal respirations
Alexia or inability to understand words written

Cerebellum

Truncal/gait ataxia, limb ataxia
Dysarthria
Vertigo, nystagmus

Real-world management of stable coronary artery disease

Dr. Choo Gim Hooi, Assoc Prof. Pattarapong Makarawate, Dr. Krisada Sastravaha, 17 Dec 2018

Coronary artery disease (CAD) is a leading cause of mortality and morbidity globally and its burden is expected to increase due to the rising prevalence of risk factors such as hypertension, diabetes, and dyslipidaemia. In conjunction with the 23rd ASEAN Federation of Cardiology Congress held in Bangkok, Thailand, Menarini organized a lunch symposium and product theatre to discuss the significance of optimal medical therapy (OMT) in the management of stable CAD, with a focus on the role of ranolazine (Ranexa^®).

Interview with Dr Titus Lau: Regional Evidence and International Recommendations to Guide Lipid Management in Asian Patients with Type 2 Diabetes with Special Reference to Renal Dysfunction

20 Dec 2017

Interview with Dr Titus Lau: Regional Evidence and International Recommendations to Guide Lipid Management in Asian Patients with Type 2 Diabetes with Special Reference to Renal Dysfunction

Empagliflozin near to us: Insights from its use in Asians

09 Jul 2020

In this fourth issue, join us as we discover the unique biology Asians have with respect to diabetes. Take a closer look at trials evaluating whether empagliflozin’s cardiovascular and renal benefits – as analysed in Asians – are consistent with the overall trial population, and how it addresses unmet needs.